We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Convalescent Plasma (CP), also called Passive Antibody Therapy, for the treatment of COVID-19 infected patients was approved by the US-FDA two weeks ago.